Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial

2018 ◽  
Vol 233 (7) ◽  
pp. 5222-5230 ◽  
Author(s):  
Sanam Dolati ◽  
Leili Aghebati-Maleki ◽  
Majid Ahmadi ◽  
Faroogh Marofi ◽  
Zohreh Babaloo ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Expression Profile ◽  
Mirna Expression ◽  
Controlled Trial ◽  
Mirna Expression Profile ◽  
Double Blind ◽  
Double Blind Placebo

Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial

2017 ◽  
Vol 36 (5) ◽  
pp. 1245-1249 ◽  
Author(s):  
Ebrahim Kouchaki ◽  
Omid Reza Tamtaji ◽  
Mahmoud Salami ◽  
Fereshteh Bahmani ◽  
Reza Daneshvar Kakhaki ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Metabolic Response ◽  
Controlled Trial ◽  
Probiotic Supplementation ◽  
Double Blind ◽  
Double Blind Placebo

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

Neurology ◽  
1997 ◽  
Vol 48 (2) ◽  
pp. 312-314 ◽  
Author(s):  
A. E. Miller ◽  
L. A. Morgante ◽  
L. Y. Buchwald ◽  
S. M. Nutile ◽  
P. K. Coyle ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Influenza Immunization
Sign in / Sign up

Export Citation Format

Share Document